nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Bexarotene—hematologic cancer	0.0438	0.0829	CbGbCtD
Conivaptan—CYP3A4—Lomustine—hematologic cancer	0.0407	0.0771	CbGbCtD
Conivaptan—CYP3A4—Busulfan—hematologic cancer	0.0407	0.0771	CbGbCtD
Conivaptan—CYP3A4—Thiotepa—hematologic cancer	0.0363	0.0687	CbGbCtD
Conivaptan—CYP3A4—Methoxsalen—hematologic cancer	0.0282	0.0534	CbGbCtD
Conivaptan—CYP3A4—Bortezomib—hematologic cancer	0.0269	0.0508	CbGbCtD
Conivaptan—CYP3A4—Daunorubicin—hematologic cancer	0.0257	0.0486	CbGbCtD
Conivaptan—CYP3A4—Cytarabine—hematologic cancer	0.0227	0.0429	CbGbCtD
Conivaptan—CYP3A4—Teniposide—hematologic cancer	0.0223	0.0422	CbGbCtD
Conivaptan—CYP3A4—Ifosfamide—hematologic cancer	0.0206	0.039	CbGbCtD
Conivaptan—CYP3A4—Imatinib—hematologic cancer	0.0197	0.0372	CbGbCtD
Conivaptan—CYP3A4—Ruxolitinib—hematologic cancer	0.0185	0.0351	CbGbCtD
Conivaptan—CYP3A4—Nilotinib—hematologic cancer	0.0179	0.0338	CbGbCtD
Conivaptan—CYP3A4—Vinorelbine—hematologic cancer	0.0177	0.0335	CbGbCtD
Conivaptan—CYP3A4—Triamcinolone—hematologic cancer	0.0162	0.0307	CbGbCtD
Conivaptan—CYP3A4—Dasatinib—hematologic cancer	0.0158	0.0299	CbGbCtD
Conivaptan—CYP3A4—Mitoxantrone—hematologic cancer	0.0156	0.0295	CbGbCtD
Conivaptan—CYP3A4—Betamethasone—hematologic cancer	0.0139	0.0263	CbGbCtD
Conivaptan—CYP3A4—Prednisolone—hematologic cancer	0.0137	0.026	CbGbCtD
Conivaptan—CYP3A4—Prednisone—hematologic cancer	0.013	0.0245	CbGbCtD
Conivaptan—CYP3A4—Irinotecan—hematologic cancer	0.0123	0.0232	CbGbCtD
Conivaptan—CYP3A4—Vinblastine—hematologic cancer	0.0109	0.0207	CbGbCtD
Conivaptan—CYP3A4—Vincristine—hematologic cancer	0.0107	0.0203	CbGbCtD
Conivaptan—CYP3A4—Etoposide—hematologic cancer	0.00984	0.0186	CbGbCtD
Conivaptan—CYP3A4—Dexamethasone—hematologic cancer	0.00809	0.0153	CbGbCtD
Conivaptan—CYP3A4—Doxorubicin—hematologic cancer	0.00671	0.0127	CbGbCtD
Conivaptan—Atorvastatin—UGT1A1—hematologic cancer	0.0016	0.444	CrCbGaD
Conivaptan—Lomitapide—ABCB1—hematologic cancer	0.00086	0.239	CrCbGaD
Conivaptan—Tolvaptan—ABCB1—hematologic cancer	0.000767	0.213	CrCbGaD
Conivaptan—Atorvastatin—ABCB1—hematologic cancer	0.000374	0.104	CrCbGaD
Conivaptan—Headache—Hydroxyurea—hematologic cancer	0.000128	0.000358	CcSEcCtD
Conivaptan—Pain—Gemcitabine—hematologic cancer	0.000128	0.000357	CcSEcCtD
Conivaptan—Constipation—Gemcitabine—hematologic cancer	0.000128	0.000357	CcSEcCtD
Conivaptan—Body temperature increased—Ifosfamide—hematologic cancer	0.000128	0.000357	CcSEcCtD
Conivaptan—Diarrhoea—Vinorelbine—hematologic cancer	0.000127	0.000356	CcSEcCtD
Conivaptan—Infection—Etoposide—hematologic cancer	0.000127	0.000354	CcSEcCtD
Conivaptan—Nausea—Melphalan—hematologic cancer	0.000126	0.000354	CcSEcCtD
Conivaptan—Feeling abnormal—Irinotecan—hematologic cancer	0.000126	0.000353	CcSEcCtD
Conivaptan—Feeling abnormal—Mitoxantrone—hematologic cancer	0.000126	0.000353	CcSEcCtD
Conivaptan—Pruritus—Thiotepa—hematologic cancer	0.000126	0.000351	CcSEcCtD
Conivaptan—Dehydration—Doxorubicin—hematologic cancer	0.000125	0.00035	CcSEcCtD
Conivaptan—Body temperature increased—Vincristine—hematologic cancer	0.000124	0.000348	CcSEcCtD
Conivaptan—Skin disorder—Etoposide—hematologic cancer	0.000124	0.000347	CcSEcCtD
Conivaptan—Feeling abnormal—Gemcitabine—hematologic cancer	0.000123	0.000344	CcSEcCtD
Conivaptan—Orthostatic hypotension—Doxorubicin—hematologic cancer	0.000123	0.000344	CcSEcCtD
Conivaptan—Nausea—Lenalidomide—hematologic cancer	0.000123	0.000344	CcSEcCtD
Conivaptan—Hypokalaemia—Doxorubicin—hematologic cancer	0.000122	0.000343	CcSEcCtD
Conivaptan—Hypertension—Triamcinolone—hematologic cancer	0.000122	0.000342	CcSEcCtD
Conivaptan—Pruritus—Thalidomide—hematologic cancer	0.000121	0.00034	CcSEcCtD
Conivaptan—Diarrhoea—Thiotepa—hematologic cancer	0.000121	0.00034	CcSEcCtD
Conivaptan—Body temperature increased—Mitoxantrone—hematologic cancer	0.000121	0.000339	CcSEcCtD
Conivaptan—Body temperature increased—Irinotecan—hematologic cancer	0.000121	0.000339	CcSEcCtD
Conivaptan—Nausea—Hydroxyurea—hematologic cancer	0.000121	0.000339	CcSEcCtD
Conivaptan—Vomiting—Bortezomib—hematologic cancer	0.000121	0.000339	CcSEcCtD
Conivaptan—Pneumonia—Methotrexate—hematologic cancer	0.00012	0.000337	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.00012	0.000336	CcSEcCtD
Conivaptan—Vomiting—Bleomycin—hematologic cancer	0.00012	0.000336	CcSEcCtD
Conivaptan—Infestation NOS—Methotrexate—hematologic cancer	0.00012	0.000335	CcSEcCtD
Conivaptan—Infestation—Methotrexate—hematologic cancer	0.00012	0.000335	CcSEcCtD
Conivaptan—Headache—Bortezomib—hematologic cancer	0.000119	0.000334	CcSEcCtD
Conivaptan—Hypotension—Etoposide—hematologic cancer	0.000119	0.000333	CcSEcCtD
Conivaptan—Pain—Cisplatin—hematologic cancer	0.000119	0.000333	CcSEcCtD
Conivaptan—Vomiting—Vinorelbine—hematologic cancer	0.000118	0.000331	CcSEcCtD
Conivaptan—Body temperature increased—Gemcitabine—hematologic cancer	0.000118	0.00033	CcSEcCtD
Conivaptan—Dry mouth—Triamcinolone—hematologic cancer	0.000118	0.00033	CcSEcCtD
Conivaptan—Diarrhoea—Thalidomide—hematologic cancer	0.000117	0.000329	CcSEcCtD
Conivaptan—Angiopathy—Prednisone—hematologic cancer	0.000117	0.000327	CcSEcCtD
Conivaptan—Headache—Vinorelbine—hematologic cancer	0.000116	0.000326	CcSEcCtD
Conivaptan—Pollakiuria—Epirubicin—hematologic cancer	0.000116	0.000325	CcSEcCtD
Conivaptan—Pruritus—Alitretinoin—hematologic cancer	0.000116	0.000323	CcSEcCtD
Conivaptan—Infection—Triamcinolone—hematologic cancer	0.000115	0.000321	CcSEcCtD
Conivaptan—Feeling abnormal—Cisplatin—hematologic cancer	0.000115	0.000321	CcSEcCtD
Conivaptan—Pruritus—Ifosfamide—hematologic cancer	0.000114	0.00032	CcSEcCtD
Conivaptan—Haematuria—Methotrexate—hematologic cancer	0.000114	0.000319	CcSEcCtD
Conivaptan—Insomnia—Prednisolone—hematologic cancer	0.000114	0.000318	CcSEcCtD
Conivaptan—Hyperglycaemia—Epirubicin—hematologic cancer	0.000113	0.000317	CcSEcCtD
Conivaptan—Nausea—Bortezomib—hematologic cancer	0.000113	0.000316	CcSEcCtD
Conivaptan—Vomiting—Thiotepa—hematologic cancer	0.000113	0.000316	CcSEcCtD
Conivaptan—Diarrhoea—Carmustine—hematologic cancer	0.000113	0.000316	CcSEcCtD
Conivaptan—Pneumonia—Epirubicin—hematologic cancer	0.000113	0.000315	CcSEcCtD
Conivaptan—Mental disorder—Prednisone—hematologic cancer	0.000113	0.000315	CcSEcCtD
Conivaptan—Nausea—Bleomycin—hematologic cancer	0.000112	0.000314	CcSEcCtD
Conivaptan—Infestation NOS—Epirubicin—hematologic cancer	0.000112	0.000314	CcSEcCtD
Conivaptan—Infestation—Epirubicin—hematologic cancer	0.000112	0.000314	CcSEcCtD
Conivaptan—Erythema—Prednisone—hematologic cancer	0.000112	0.000313	CcSEcCtD
Conivaptan—Malnutrition—Prednisone—hematologic cancer	0.000112	0.000313	CcSEcCtD
Conivaptan—Diarrhoea—Alitretinoin—hematologic cancer	0.000112	0.000313	CcSEcCtD
Conivaptan—Headache—Thiotepa—hematologic cancer	0.000111	0.000311	CcSEcCtD
Conivaptan—Hypertension—Betamethasone—hematologic cancer	0.000111	0.000311	CcSEcCtD
Conivaptan—Hypertension—Dexamethasone—hematologic cancer	0.000111	0.000311	CcSEcCtD
Conivaptan—Diarrhoea—Ifosfamide—hematologic cancer	0.00011	0.000309	CcSEcCtD
Conivaptan—Nausea—Vinorelbine—hematologic cancer	0.00011	0.000309	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Etoposide—hematologic cancer	0.00011	0.000308	CcSEcCtD
Conivaptan—Body temperature increased—Cisplatin—hematologic cancer	0.00011	0.000308	CcSEcCtD
Conivaptan—Vomiting—Thalidomide—hematologic cancer	0.000109	0.000305	CcSEcCtD
Conivaptan—Constipation—Etoposide—hematologic cancer	0.000109	0.000305	CcSEcCtD
Conivaptan—Pain—Etoposide—hematologic cancer	0.000109	0.000305	CcSEcCtD
Conivaptan—Urinary tract infection—Epirubicin—hematologic cancer	0.000109	0.000305	CcSEcCtD
Conivaptan—Diarrhoea—Vincristine—hematologic cancer	0.000108	0.000301	CcSEcCtD
Conivaptan—Headache—Thalidomide—hematologic cancer	0.000108	0.000301	CcSEcCtD
Conivaptan—Pain—Prednisolone—hematologic cancer	0.000108	0.000301	CcSEcCtD
Conivaptan—Pollakiuria—Doxorubicin—hematologic cancer	0.000107	0.000301	CcSEcCtD
Conivaptan—Haematuria—Epirubicin—hematologic cancer	0.000107	0.000299	CcSEcCtD
Conivaptan—Urinary tract disorder—Methotrexate—hematologic cancer	0.000106	0.000297	CcSEcCtD
Conivaptan—Pruritus—Gemcitabine—hematologic cancer	0.000106	0.000296	CcSEcCtD
Conivaptan—Nausea—Thiotepa—hematologic cancer	0.000105	0.000295	CcSEcCtD
Conivaptan—Urethral disorder—Methotrexate—hematologic cancer	0.000105	0.000295	CcSEcCtD
Conivaptan—Feeling abnormal—Etoposide—hematologic cancer	0.000105	0.000294	CcSEcCtD
Conivaptan—Hyperglycaemia—Doxorubicin—hematologic cancer	0.000105	0.000294	CcSEcCtD
Conivaptan—Diarrhoea—Irinotecan—hematologic cancer	0.000105	0.000293	CcSEcCtD
Conivaptan—Diarrhoea—Mitoxantrone—hematologic cancer	0.000105	0.000293	CcSEcCtD
Conivaptan—Vomiting—Carmustine—hematologic cancer	0.000105	0.000293	CcSEcCtD
Conivaptan—Insomnia—Triamcinolone—hematologic cancer	0.000105	0.000293	CcSEcCtD
Conivaptan—Pneumonia—Doxorubicin—hematologic cancer	0.000104	0.000292	CcSEcCtD
Conivaptan—Infection—Dexamethasone—hematologic cancer	0.000104	0.000292	CcSEcCtD
Conivaptan—Infection—Betamethasone—hematologic cancer	0.000104	0.000292	CcSEcCtD
Conivaptan—Vomiting—Alitretinoin—hematologic cancer	0.000104	0.000291	CcSEcCtD
Conivaptan—Infestation NOS—Doxorubicin—hematologic cancer	0.000104	0.00029	CcSEcCtD
Conivaptan—Infestation—Doxorubicin—hematologic cancer	0.000104	0.00029	CcSEcCtD
Conivaptan—Feeling abnormal—Prednisolone—hematologic cancer	0.000104	0.00029	CcSEcCtD
Conivaptan—Anaemia—Prednisone—hematologic cancer	0.000103	0.00029	CcSEcCtD
Conivaptan—Headache—Carmustine—hematologic cancer	0.000103	0.000289	CcSEcCtD
Conivaptan—Nervous system disorder—Dexamethasone—hematologic cancer	0.000103	0.000288	CcSEcCtD
Conivaptan—Nervous system disorder—Betamethasone—hematologic cancer	0.000103	0.000288	CcSEcCtD
Conivaptan—Vomiting—Ifosfamide—hematologic cancer	0.000103	0.000287	CcSEcCtD
Conivaptan—Headache—Alitretinoin—hematologic cancer	0.000102	0.000286	CcSEcCtD
Conivaptan—Diarrhoea—Gemcitabine—hematologic cancer	0.000102	0.000286	CcSEcCtD
Conivaptan—Nausea—Thalidomide—hematologic cancer	0.000102	0.000285	CcSEcCtD
Conivaptan—Body temperature increased—Etoposide—hematologic cancer	0.000101	0.000282	CcSEcCtD
Conivaptan—Urinary tract infection—Doxorubicin—hematologic cancer	0.000101	0.000282	CcSEcCtD
Conivaptan—Vomiting—Vincristine—hematologic cancer	0.0001	0.00028	CcSEcCtD
Conivaptan—Cardiac disorder—Methotrexate—hematologic cancer	9.98e-05	0.000279	CcSEcCtD
Conivaptan—Urinary tract disorder—Epirubicin—hematologic cancer	9.93e-05	0.000278	CcSEcCtD
Conivaptan—Oedema peripheral—Epirubicin—hematologic cancer	9.91e-05	0.000277	CcSEcCtD
Conivaptan—Pain—Triamcinolone—hematologic cancer	9.89e-05	0.000277	CcSEcCtD
Conivaptan—Haematuria—Doxorubicin—hematologic cancer	9.89e-05	0.000277	CcSEcCtD
Conivaptan—Urethral disorder—Epirubicin—hematologic cancer	9.86e-05	0.000276	CcSEcCtD
Conivaptan—Headache—Vincristine—hematologic cancer	9.86e-05	0.000276	CcSEcCtD
Conivaptan—Hypotension—Betamethasone—hematologic cancer	9.81e-05	0.000274	CcSEcCtD
Conivaptan—Hypotension—Dexamethasone—hematologic cancer	9.81e-05	0.000274	CcSEcCtD
Conivaptan—Nausea—Carmustine—hematologic cancer	9.79e-05	0.000274	CcSEcCtD
Conivaptan—Angiopathy—Methotrexate—hematologic cancer	9.75e-05	0.000273	CcSEcCtD
Conivaptan—Vomiting—Irinotecan—hematologic cancer	9.75e-05	0.000273	CcSEcCtD
Conivaptan—Vomiting—Mitoxantrone—hematologic cancer	9.75e-05	0.000273	CcSEcCtD
Conivaptan—Nausea—Alitretinoin—hematologic cancer	9.7e-05	0.000271	CcSEcCtD
Conivaptan—Mediastinal disorder—Methotrexate—hematologic cancer	9.69e-05	0.000271	CcSEcCtD
Conivaptan—Hypertension—Prednisone—hematologic cancer	9.67e-05	0.000271	CcSEcCtD
Conivaptan—Headache—Irinotecan—hematologic cancer	9.6e-05	0.000269	CcSEcCtD
Conivaptan—Headache—Mitoxantrone—hematologic cancer	9.6e-05	0.000269	CcSEcCtD
Conivaptan—Nausea—Ifosfamide—hematologic cancer	9.59e-05	0.000268	CcSEcCtD
Conivaptan—Feeling abnormal—Triamcinolone—hematologic cancer	9.53e-05	0.000267	CcSEcCtD
Conivaptan—Diarrhoea—Cisplatin—hematologic cancer	9.52e-05	0.000266	CcSEcCtD
Conivaptan—Vomiting—Gemcitabine—hematologic cancer	9.49e-05	0.000266	CcSEcCtD
Conivaptan—Insomnia—Dexamethasone—hematologic cancer	9.49e-05	0.000266	CcSEcCtD
Conivaptan—Insomnia—Betamethasone—hematologic cancer	9.49e-05	0.000266	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	9.47e-05	0.000265	CcSEcCtD
Conivaptan—Mental disorder—Methotrexate—hematologic cancer	9.42e-05	0.000264	CcSEcCtD
Conivaptan—Malnutrition—Methotrexate—hematologic cancer	9.36e-05	0.000262	CcSEcCtD
Conivaptan—Erythema—Methotrexate—hematologic cancer	9.36e-05	0.000262	CcSEcCtD
Conivaptan—Headache—Gemcitabine—hematologic cancer	9.35e-05	0.000262	CcSEcCtD
Conivaptan—Nausea—Vincristine—hematologic cancer	9.35e-05	0.000262	CcSEcCtD
Conivaptan—Cardiac disorder—Epirubicin—hematologic cancer	9.34e-05	0.000261	CcSEcCtD
Conivaptan—Urinary tract disorder—Doxorubicin—hematologic cancer	9.19e-05	0.000257	CcSEcCtD
Conivaptan—Oedema peripheral—Doxorubicin—hematologic cancer	9.17e-05	0.000257	CcSEcCtD
Conivaptan—Body temperature increased—Triamcinolone—hematologic cancer	9.14e-05	0.000256	CcSEcCtD
Conivaptan—Angiopathy—Epirubicin—hematologic cancer	9.13e-05	0.000255	CcSEcCtD
Conivaptan—Urethral disorder—Doxorubicin—hematologic cancer	9.12e-05	0.000255	CcSEcCtD
Conivaptan—Nausea—Irinotecan—hematologic cancer	9.11e-05	0.000255	CcSEcCtD
Conivaptan—Nausea—Mitoxantrone—hematologic cancer	9.11e-05	0.000255	CcSEcCtD
Conivaptan—Infection—Prednisone—hematologic cancer	9.08e-05	0.000254	CcSEcCtD
Conivaptan—Mediastinal disorder—Epirubicin—hematologic cancer	9.07e-05	0.000254	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Dexamethasone—hematologic cancer	9.06e-05	0.000253	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Betamethasone—hematologic cancer	9.06e-05	0.000253	CcSEcCtD
Conivaptan—Pruritus—Etoposide—hematologic cancer	9.02e-05	0.000252	CcSEcCtD
Conivaptan—Pain—Betamethasone—hematologic cancer	8.97e-05	0.000251	CcSEcCtD
Conivaptan—Pain—Dexamethasone—hematologic cancer	8.97e-05	0.000251	CcSEcCtD
Conivaptan—Nervous system disorder—Prednisone—hematologic cancer	8.96e-05	0.000251	CcSEcCtD
Conivaptan—Skin disorder—Prednisone—hematologic cancer	8.88e-05	0.000248	CcSEcCtD
Conivaptan—Nausea—Gemcitabine—hematologic cancer	8.87e-05	0.000248	CcSEcCtD
Conivaptan—Vomiting—Cisplatin—hematologic cancer	8.85e-05	0.000248	CcSEcCtD
Conivaptan—Mental disorder—Epirubicin—hematologic cancer	8.81e-05	0.000247	CcSEcCtD
Conivaptan—Erythema—Epirubicin—hematologic cancer	8.76e-05	0.000245	CcSEcCtD
Conivaptan—Malnutrition—Epirubicin—hematologic cancer	8.76e-05	0.000245	CcSEcCtD
Conivaptan—Diarrhoea—Etoposide—hematologic cancer	8.72e-05	0.000244	CcSEcCtD
Conivaptan—Anaemia—Methotrexate—hematologic cancer	8.65e-05	0.000242	CcSEcCtD
Conivaptan—Feeling abnormal—Dexamethasone—hematologic cancer	8.65e-05	0.000242	CcSEcCtD
Conivaptan—Feeling abnormal—Betamethasone—hematologic cancer	8.65e-05	0.000242	CcSEcCtD
Conivaptan—Cardiac disorder—Doxorubicin—hematologic cancer	8.64e-05	0.000242	CcSEcCtD
Conivaptan—Angiopathy—Doxorubicin—hematologic cancer	8.45e-05	0.000236	CcSEcCtD
Conivaptan—Mediastinal disorder—Doxorubicin—hematologic cancer	8.39e-05	0.000235	CcSEcCtD
Conivaptan—Body temperature increased—Dexamethasone—hematologic cancer	8.3e-05	0.000232	CcSEcCtD
Conivaptan—Body temperature increased—Betamethasone—hematologic cancer	8.3e-05	0.000232	CcSEcCtD
Conivaptan—Nausea—Cisplatin—hematologic cancer	8.27e-05	0.000231	CcSEcCtD
Conivaptan—Insomnia—Prednisone—hematologic cancer	8.27e-05	0.000231	CcSEcCtD
Conivaptan—Pruritus—Triamcinolone—hematologic cancer	8.18e-05	0.000229	CcSEcCtD
Conivaptan—Mental disorder—Doxorubicin—hematologic cancer	8.16e-05	0.000228	CcSEcCtD
Conivaptan—Vomiting—Etoposide—hematologic cancer	8.11e-05	0.000227	CcSEcCtD
Conivaptan—Erythema—Doxorubicin—hematologic cancer	8.1e-05	0.000227	CcSEcCtD
Conivaptan—Malnutrition—Doxorubicin—hematologic cancer	8.1e-05	0.000227	CcSEcCtD
Conivaptan—Anaemia—Epirubicin—hematologic cancer	8.09e-05	0.000226	CcSEcCtD
Conivaptan—Headache—Etoposide—hematologic cancer	7.99e-05	0.000224	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	7.91e-05	0.000221	CcSEcCtD
Conivaptan—Headache—Prednisolone—hematologic cancer	7.88e-05	0.00022	CcSEcCtD
Conivaptan—Constipation—Prednisone—hematologic cancer	7.81e-05	0.000219	CcSEcCtD
Conivaptan—Confusional state—Methotrexate—hematologic cancer	7.7e-05	0.000215	CcSEcCtD
Conivaptan—Infection—Methotrexate—hematologic cancer	7.59e-05	0.000212	CcSEcCtD
Conivaptan—Nausea—Etoposide—hematologic cancer	7.57e-05	0.000212	CcSEcCtD
Conivaptan—Hypertension—Epirubicin—hematologic cancer	7.56e-05	0.000212	CcSEcCtD
Conivaptan—Feeling abnormal—Prednisone—hematologic cancer	7.53e-05	0.000211	CcSEcCtD
Conivaptan—Nervous system disorder—Methotrexate—hematologic cancer	7.49e-05	0.00021	CcSEcCtD
Conivaptan—Anaemia—Doxorubicin—hematologic cancer	7.49e-05	0.00021	CcSEcCtD
Conivaptan—Nausea—Prednisolone—hematologic cancer	7.47e-05	0.000209	CcSEcCtD
Conivaptan—Pruritus—Betamethasone—hematologic cancer	7.42e-05	0.000208	CcSEcCtD
Conivaptan—Pruritus—Dexamethasone—hematologic cancer	7.42e-05	0.000208	CcSEcCtD
Conivaptan—Skin disorder—Methotrexate—hematologic cancer	7.42e-05	0.000208	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	7.4e-05	0.000207	CcSEcCtD
Conivaptan—Vomiting—Triamcinolone—hematologic cancer	7.35e-05	0.000206	CcSEcCtD
Conivaptan—Dry mouth—Epirubicin—hematologic cancer	7.29e-05	0.000204	CcSEcCtD
Conivaptan—Headache—Triamcinolone—hematologic cancer	7.25e-05	0.000203	CcSEcCtD
Conivaptan—Body temperature increased—Prednisone—hematologic cancer	7.22e-05	0.000202	CcSEcCtD
Conivaptan—Confusional state—Epirubicin—hematologic cancer	7.21e-05	0.000202	CcSEcCtD
Conivaptan—Diarrhoea—Dexamethasone—hematologic cancer	7.18e-05	0.000201	CcSEcCtD
Conivaptan—Diarrhoea—Betamethasone—hematologic cancer	7.18e-05	0.000201	CcSEcCtD
Conivaptan—Hypotension—Methotrexate—hematologic cancer	7.14e-05	0.0002	CcSEcCtD
Conivaptan—Infection—Epirubicin—hematologic cancer	7.1e-05	0.000199	CcSEcCtD
Conivaptan—Nervous system disorder—Epirubicin—hematologic cancer	7.01e-05	0.000196	CcSEcCtD
Conivaptan—Hypertension—Doxorubicin—hematologic cancer	7e-05	0.000196	CcSEcCtD
Conivaptan—Skin disorder—Epirubicin—hematologic cancer	6.94e-05	0.000194	CcSEcCtD
Conivaptan—Insomnia—Methotrexate—hematologic cancer	6.91e-05	0.000193	CcSEcCtD
Conivaptan—Nausea—Triamcinolone—hematologic cancer	6.87e-05	0.000192	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	6.85e-05	0.000192	CcSEcCtD
Conivaptan—Dry mouth—Doxorubicin—hematologic cancer	6.75e-05	0.000189	CcSEcCtD
Conivaptan—Hypotension—Epirubicin—hematologic cancer	6.68e-05	0.000187	CcSEcCtD
Conivaptan—Vomiting—Betamethasone—hematologic cancer	6.67e-05	0.000187	CcSEcCtD
Conivaptan—Vomiting—Dexamethasone—hematologic cancer	6.67e-05	0.000187	CcSEcCtD
Conivaptan—Confusional state—Doxorubicin—hematologic cancer	6.67e-05	0.000187	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.59e-05	0.000184	CcSEcCtD
Conivaptan—Headache—Betamethasone—hematologic cancer	6.57e-05	0.000184	CcSEcCtD
Conivaptan—Headache—Dexamethasone—hematologic cancer	6.57e-05	0.000184	CcSEcCtD
Conivaptan—Infection—Doxorubicin—hematologic cancer	6.57e-05	0.000184	CcSEcCtD
Conivaptan—Pain—Methotrexate—hematologic cancer	6.53e-05	0.000183	CcSEcCtD
Conivaptan—Nervous system disorder—Doxorubicin—hematologic cancer	6.49e-05	0.000181	CcSEcCtD
Conivaptan—Pruritus—Prednisone—hematologic cancer	6.47e-05	0.000181	CcSEcCtD
Conivaptan—Insomnia—Epirubicin—hematologic cancer	6.46e-05	0.000181	CcSEcCtD
Conivaptan—Skin disorder—Doxorubicin—hematologic cancer	6.42e-05	0.00018	CcSEcCtD
Conivaptan—Feeling abnormal—Methotrexate—hematologic cancer	6.29e-05	0.000176	CcSEcCtD
Conivaptan—Diarrhoea—Prednisone—hematologic cancer	6.25e-05	0.000175	CcSEcCtD
Conivaptan—Nausea—Betamethasone—hematologic cancer	6.23e-05	0.000174	CcSEcCtD
Conivaptan—Nausea—Dexamethasone—hematologic cancer	6.23e-05	0.000174	CcSEcCtD
Conivaptan—Hypotension—Doxorubicin—hematologic cancer	6.18e-05	0.000173	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Epirubicin—hematologic cancer	6.17e-05	0.000173	CcSEcCtD
Conivaptan—Pain—Epirubicin—hematologic cancer	6.11e-05	0.000171	CcSEcCtD
Conivaptan—Constipation—Epirubicin—hematologic cancer	6.11e-05	0.000171	CcSEcCtD
Conivaptan—Body temperature increased—Methotrexate—hematologic cancer	6.04e-05	0.000169	CcSEcCtD
Conivaptan—Insomnia—Doxorubicin—hematologic cancer	5.98e-05	0.000167	CcSEcCtD
Conivaptan—Feeling abnormal—Epirubicin—hematologic cancer	5.89e-05	0.000165	CcSEcCtD
Conivaptan—Vomiting—Prednisone—hematologic cancer	5.81e-05	0.000163	CcSEcCtD
Conivaptan—Headache—Prednisone—hematologic cancer	5.72e-05	0.00016	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.71e-05	0.00016	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CG—hematologic cancer	5.69e-05	0.000515	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTPN1—hematologic cancer	5.66e-05	0.000513	CbGpPWpGaD
Conivaptan—Pain—Doxorubicin—hematologic cancer	5.66e-05	0.000158	CcSEcCtD
Conivaptan—Constipation—Doxorubicin—hematologic cancer	5.66e-05	0.000158	CcSEcCtD
Conivaptan—Body temperature increased—Epirubicin—hematologic cancer	5.65e-05	0.000158	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—PTPN11—hematologic cancer	5.63e-05	0.00051	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RASGRP1—hematologic cancer	5.61e-05	0.000508	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HSP90AA1—hematologic cancer	5.59e-05	0.000507	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SYK—hematologic cancer	5.59e-05	0.000507	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PTPN11—hematologic cancer	5.59e-05	0.000506	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RASGRP1—hematologic cancer	5.57e-05	0.000505	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SYK—hematologic cancer	5.55e-05	0.000503	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HSP90AA1—hematologic cancer	5.55e-05	0.000503	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CD—hematologic cancer	5.55e-05	0.000503	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CD—hematologic cancer	5.51e-05	0.000499	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CREB1—hematologic cancer	5.45e-05	0.000494	CbGpPWpGaD
Conivaptan—Feeling abnormal—Doxorubicin—hematologic cancer	5.45e-05	0.000152	CcSEcCtD
Conivaptan—Nausea—Prednisone—hematologic cancer	5.43e-05	0.000152	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—CREB1—hematologic cancer	5.41e-05	0.000491	CbGpPWpGaD
Conivaptan—Pruritus—Methotrexate—hematologic cancer	5.4e-05	0.000151	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—STAT1—hematologic cancer	5.39e-05	0.000489	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—STAT1—hematologic cancer	5.35e-05	0.000485	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCL2—hematologic cancer	5.34e-05	0.000484	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6R—hematologic cancer	5.32e-05	0.000482	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL2—hematologic cancer	5.3e-05	0.00048	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6R—hematologic cancer	5.28e-05	0.000479	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3R1—hematologic cancer	5.24e-05	0.000475	CbGpPWpGaD
Conivaptan—Body temperature increased—Doxorubicin—hematologic cancer	5.23e-05	0.000146	CcSEcCtD
Conivaptan—Diarrhoea—Methotrexate—hematologic cancer	5.23e-05	0.000146	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3R1—hematologic cancer	5.2e-05	0.000471	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—JAK2—hematologic cancer	5.09e-05	0.000461	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—MAP2K1—hematologic cancer	5.07e-05	0.000459	CbGpPWpGaD
Conivaptan—Pruritus—Epirubicin—hematologic cancer	5.06e-05	0.000141	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—JAK2—hematologic cancer	5.05e-05	0.000458	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GRB2—hematologic cancer	5.04e-05	0.000457	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CD—hematologic cancer	5.04e-05	0.000456	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—MAP2K1—hematologic cancer	5.03e-05	0.000456	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PDGFA—hematologic cancer	5.03e-05	0.000456	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GRB2—hematologic cancer	5.01e-05	0.000454	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CD—hematologic cancer	5e-05	0.000453	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PDGFA—hematologic cancer	5e-05	0.000453	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KITLG—hematologic cancer	4.96e-05	0.00045	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KITLG—hematologic cancer	4.92e-05	0.000446	CbGpPWpGaD
Conivaptan—Diarrhoea—Epirubicin—hematologic cancer	4.89e-05	0.000137	CcSEcCtD
Conivaptan—Vomiting—Methotrexate—hematologic cancer	4.86e-05	0.000136	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—STAT5A—hematologic cancer	4.85e-05	0.000439	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CB—hematologic cancer	4.83e-05	0.000438	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—STAT5A—hematologic cancer	4.81e-05	0.000436	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CDKN2B—hematologic cancer	4.81e-05	0.000436	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CB—hematologic cancer	4.8e-05	0.000435	CbGpPWpGaD
Conivaptan—Headache—Methotrexate—hematologic cancer	4.78e-05	0.000134	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—CDKN2B—hematologic cancer	4.77e-05	0.000432	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3R1—hematologic cancer	4.76e-05	0.000431	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3R1—hematologic cancer	4.72e-05	0.000428	CbGpPWpGaD
Conivaptan—Pruritus—Doxorubicin—hematologic cancer	4.68e-05	0.000131	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CD86—hematologic cancer	4.65e-05	0.000421	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—JAK2—hematologic cancer	4.62e-05	0.000419	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CD86—hematologic cancer	4.61e-05	0.000418	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—JAK2—hematologic cancer	4.59e-05	0.000416	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HES1—hematologic cancer	4.58e-05	0.000415	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NCOR1—hematologic cancer	4.56e-05	0.000413	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HES1—hematologic cancer	4.55e-05	0.000412	CbGpPWpGaD
Conivaptan—Vomiting—Epirubicin—hematologic cancer	4.54e-05	0.000127	CcSEcCtD
Conivaptan—Nausea—Methotrexate—hematologic cancer	4.54e-05	0.000127	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—NCOR1—hematologic cancer	4.53e-05	0.00041	CbGpPWpGaD
Conivaptan—Diarrhoea—Doxorubicin—hematologic cancer	4.52e-05	0.000127	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—FGF1—hematologic cancer	4.51e-05	0.000408	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CSF2—hematologic cancer	4.51e-05	0.000408	CbGpPWpGaD
Conivaptan—Headache—Epirubicin—hematologic cancer	4.48e-05	0.000125	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—CSF2—hematologic cancer	4.48e-05	0.000406	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGF1—hematologic cancer	4.48e-05	0.000406	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FOXO1—hematologic cancer	4.44e-05	0.000403	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—IL2—hematologic cancer	4.44e-05	0.000402	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PDGFRB—hematologic cancer	4.43e-05	0.000402	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FOXO1—hematologic cancer	4.41e-05	0.0004	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—IL2—hematologic cancer	4.41e-05	0.000399	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PDGFRB—hematologic cancer	4.4e-05	0.000399	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CB—hematologic cancer	4.39e-05	0.000398	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PDGFRA—hematologic cancer	4.37e-05	0.000396	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CB—hematologic cancer	4.36e-05	0.000395	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—JAK1—hematologic cancer	4.35e-05	0.000394	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRKCG—hematologic cancer	4.35e-05	0.000394	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PDGFRA—hematologic cancer	4.33e-05	0.000393	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRKCG—hematologic cancer	4.32e-05	0.000391	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—JAK1—hematologic cancer	4.32e-05	0.000391	CbGpPWpGaD
Conivaptan—Nausea—Epirubicin—hematologic cancer	4.25e-05	0.000119	CcSEcCtD
Conivaptan—Vomiting—Doxorubicin—hematologic cancer	4.2e-05	0.000118	CcSEcCtD
Conivaptan—Headache—Doxorubicin—hematologic cancer	4.14e-05	0.000116	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—IL2RA—hematologic cancer	4.06e-05	0.000368	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	4.04e-05	0.000366	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL2RA—hematologic cancer	4.03e-05	0.000366	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL2—hematologic cancer	4.03e-05	0.000365	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TERT—hematologic cancer	4.02e-05	0.000364	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL2—hematologic cancer	4e-05	0.000363	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TERT—hematologic cancer	3.99e-05	0.000361	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	3.99e-05	0.000361	CbGpPWpGaD
Conivaptan—Nausea—Doxorubicin—hematologic cancer	3.93e-05	0.00011	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—PDGFB—hematologic cancer	3.92e-05	0.000355	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PDGFB—hematologic cancer	3.89e-05	0.000353	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TSC2—hematologic cancer	3.83e-05	0.000347	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TSC2—hematologic cancer	3.81e-05	0.000345	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	3.71e-05	0.000337	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FGFR3—hematologic cancer	3.69e-05	0.000334	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	3.66e-05	0.000332	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGFR3—hematologic cancer	3.66e-05	0.000332	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK14—hematologic cancer	3.65e-05	0.000331	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK14—hematologic cancer	3.62e-05	0.000328	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ESR1—hematologic cancer	3.58e-05	0.000324	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ESR1—hematologic cancer	3.56e-05	0.000322	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FN1—hematologic cancer	3.54e-05	0.000321	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FN1—hematologic cancer	3.51e-05	0.000318	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—BAD—hematologic cancer	3.49e-05	0.000317	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NFKBIA—hematologic cancer	3.49e-05	0.000317	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NFKBIA—hematologic cancer	3.47e-05	0.000314	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—BAD—hematologic cancer	3.47e-05	0.000314	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOTCH1—hematologic cancer	3.46e-05	0.000314	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOTCH1—hematologic cancer	3.44e-05	0.000311	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CD80—hematologic cancer	3.39e-05	0.000307	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KIT—hematologic cancer	3.38e-05	0.000307	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CG—hematologic cancer	3.38e-05	0.000307	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—NRAS—hematologic cancer	3.38e-05	0.000307	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CD80—hematologic cancer	3.37e-05	0.000305	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KIT—hematologic cancer	3.36e-05	0.000305	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CG—hematologic cancer	3.36e-05	0.000305	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—NRAS—hematologic cancer	3.36e-05	0.000305	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTPN11—hematologic cancer	3.33e-05	0.000301	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTPN11—hematologic cancer	3.3e-05	0.000299	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—MAPK3—hematologic cancer	3.24e-05	0.000294	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CREB1—hematologic cancer	3.22e-05	0.000292	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—MAPK3—hematologic cancer	3.22e-05	0.000292	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CREB1—hematologic cancer	3.2e-05	0.00029	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—BRAF—hematologic cancer	3.18e-05	0.000288	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—BRAF—hematologic cancer	3.16e-05	0.000286	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL2—hematologic cancer	3.15e-05	0.000286	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6R—hematologic cancer	3.14e-05	0.000285	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CREBBP—hematologic cancer	3.14e-05	0.000284	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL2—hematologic cancer	3.13e-05	0.000284	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6R—hematologic cancer	3.12e-05	0.000283	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CREBBP—hematologic cancer	3.12e-05	0.000282	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PHYH—hematologic cancer	3.1e-05	0.000281	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GMPS—hematologic cancer	3.1e-05	0.000281	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—FTCD—hematologic cancer	3.1e-05	0.000281	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAP2K1—hematologic cancer	3e-05	0.000271	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CD—hematologic cancer	2.98e-05	0.00027	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAP2K1—hematologic cancer	2.97e-05	0.000269	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CD—hematologic cancer	2.95e-05	0.000268	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CA—hematologic cancer	2.95e-05	0.000267	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CA—hematologic cancer	2.93e-05	0.000265	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—KRAS—hematologic cancer	2.91e-05	0.000264	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—KRAS—hematologic cancer	2.89e-05	0.000262	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FGF2—hematologic cancer	2.85e-05	0.000258	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SMPD3—hematologic cancer	2.83e-05	0.000257	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGF2—hematologic cancer	2.83e-05	0.000256	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3R1—hematologic cancer	2.81e-05	0.000255	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3R1—hematologic cancer	2.79e-05	0.000253	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—JAK2—hematologic cancer	2.73e-05	0.000247	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—JAK2—hematologic cancer	2.71e-05	0.000246	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CA—hematologic cancer	2.68e-05	0.000243	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MDM2—hematologic cancer	2.67e-05	0.000242	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CA—hematologic cancer	2.66e-05	0.000241	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MDM2—hematologic cancer	2.65e-05	0.00024	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CB—hematologic cancer	2.59e-05	0.000235	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MTOR—hematologic cancer	2.59e-05	0.000235	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CB—hematologic cancer	2.57e-05	0.000233	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MTOR—hematologic cancer	2.57e-05	0.000233	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HRAS—hematologic cancer	2.48e-05	0.000224	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ASNS—hematologic cancer	2.48e-05	0.000224	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DCK—hematologic cancer	2.48e-05	0.000224	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—B3GAT1—hematologic cancer	2.48e-05	0.000224	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HRAS—hematologic cancer	2.46e-05	0.000223	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CDKN1B—hematologic cancer	2.43e-05	0.000221	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CDKN1B—hematologic cancer	2.42e-05	0.000219	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AKT1—hematologic cancer	2.41e-05	0.000218	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AKT1—hematologic cancer	2.39e-05	0.000217	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CASP3—hematologic cancer	2.39e-05	0.000216	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL2—hematologic cancer	2.38e-05	0.000216	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—hematologic cancer	2.37e-05	0.000215	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CASP3—hematologic cancer	2.37e-05	0.000215	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL2—hematologic cancer	2.36e-05	0.000214	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—hematologic cancer	2.35e-05	0.000213	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HDC—hematologic cancer	2.35e-05	0.000213	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCND1—hematologic cancer	2.32e-05	0.00021	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—JUN—hematologic cancer	2.32e-05	0.00021	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCND1—hematologic cancer	2.31e-05	0.000209	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—JUN—hematologic cancer	2.3e-05	0.000208	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CDKN1A—hematologic cancer	2.25e-05	0.000204	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTEN—hematologic cancer	2.24e-05	0.000203	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CDKN1A—hematologic cancer	2.23e-05	0.000202	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTEN—hematologic cancer	2.23e-05	0.000202	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK8—hematologic cancer	2.19e-05	0.000199	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AKT1—hematologic cancer	2.19e-05	0.000198	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK8—hematologic cancer	2.18e-05	0.000197	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AKT1—hematologic cancer	2.17e-05	0.000197	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CDA—hematologic cancer	2.15e-05	0.000195	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EP300—hematologic cancer	2.14e-05	0.000194	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EP300—hematologic cancer	2.12e-05	0.000192	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SRC—hematologic cancer	2.08e-05	0.000188	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PC—hematologic cancer	2.07e-05	0.000187	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SRC—hematologic cancer	2.06e-05	0.000187	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VEGFA—hematologic cancer	2.02e-05	0.000183	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VEGFA—hematologic cancer	2.01e-05	0.000182	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—STAT3—hematologic cancer	2e-05	0.000182	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NRAS—hematologic cancer	2e-05	0.000181	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC35B2—hematologic cancer	2e-05	0.000181	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GBA—hematologic cancer	2e-05	0.000181	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—STAT3—hematologic cancer	1.99e-05	0.00018	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NRAS—hematologic cancer	1.99e-05	0.00018	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK3—hematologic cancer	1.91e-05	0.000174	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK3—hematologic cancer	1.9e-05	0.000172	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MYC—hematologic cancer	1.86e-05	0.000169	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFB1—hematologic cancer	1.86e-05	0.000168	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MYC—hematologic cancer	1.85e-05	0.000168	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFB1—hematologic cancer	1.84e-05	0.000167	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTAP—hematologic cancer	1.83e-05	0.000165	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KRAS—hematologic cancer	1.72e-05	0.000156	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KRAS—hematologic cancer	1.71e-05	0.000155	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—FHL2—hematologic cancer	1.63e-05	0.000147	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AGRN—hematologic cancer	1.6e-05	0.000145	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CA—hematologic cancer	1.58e-05	0.000143	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CA—hematologic cancer	1.57e-05	0.000142	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TP53—hematologic cancer	1.53e-05	0.000139	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TP53—hematologic cancer	1.52e-05	0.000138	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—IDH2—hematologic cancer	1.51e-05	0.000137	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMMR—hematologic cancer	1.51e-05	0.000137	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HRAS—hematologic cancer	1.46e-05	0.000133	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HRAS—hematologic cancer	1.45e-05	0.000132	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.42e-05	0.000129	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—hematologic cancer	1.4e-05	0.000127	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—hematologic cancer	1.39e-05	0.000126	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CA9—hematologic cancer	1.38e-05	0.000125	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ACP5—hematologic cancer	1.38e-05	0.000125	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.37e-05	0.000124	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—IDH1—hematologic cancer	1.3e-05	0.000118	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT1—hematologic cancer	1.29e-05	0.000117	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TXN—hematologic cancer	1.29e-05	0.000117	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.29e-05	0.000117	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.29e-05	0.000117	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT1—hematologic cancer	1.28e-05	0.000116	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.26e-05	0.000114	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.21e-05	0.00011	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.18e-05	0.000107	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.18e-05	0.000107	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.15e-05	0.000104	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NUP98—hematologic cancer	1.11e-05	0.000101	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.08e-05	9.77e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.08e-05	9.77e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NUP214—hematologic cancer	1.07e-05	9.7e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTR—hematologic cancer	1.05e-05	9.5e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.05e-05	9.5e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ENO2—hematologic cancer	1.03e-05	9.32e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTT1—hematologic cancer	9.97e-06	9.04e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SDC1—hematologic cancer	9.75e-06	8.83e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CD44—hematologic cancer	8.29e-06	7.51e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NQO1—hematologic cancer	8.29e-06	7.51e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYCS—hematologic cancer	7.84e-06	7.11e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	7.79e-06	7.06e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTP1—hematologic cancer	6.91e-06	6.26e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCB1—hematologic cancer	6.54e-06	5.93e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTM1—hematologic cancer	6.35e-06	5.76e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NCOR1—hematologic cancer	6.35e-06	5.76e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTHFR—hematologic cancer	5.61e-06	5.09e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CG—hematologic cancer	4.72e-06	4.27e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CREBBP—hematologic cancer	4.37e-06	3.96e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CD—hematologic cancer	4.15e-06	3.76e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALB—hematologic cancer	4.09e-06	3.71e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.92e-06	3.55e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.61e-06	3.28e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTEN—hematologic cancer	3.12e-06	2.83e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—EP300—hematologic cancer	2.98e-06	2.7e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.2e-06	2e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKT1—hematologic cancer	1.8e-06	1.63e-05	CbGpPWpGaD
